889 related articles for article (PubMed ID: 16684163)
1. Effect of nurse-led gut-directed hypnotherapy upon health-related quality of life in patients with irritable bowel syndrome.
Smith GD
J Clin Nurs; 2006 Jun; 15(6):678-84. PubMed ID: 16684163
[TBL] [Abstract][Full Text] [Related]
2. Gut-directed hypnotherapy for irritable bowel syndrome: piloting a primary care-based randomised controlled trial.
Roberts L; Wilson S; Singh S; Roalfe A; Greenfield S
Br J Gen Pract; 2006 Feb; 56(523):115-21. PubMed ID: 16464325
[TBL] [Abstract][Full Text] [Related]
3. Cognitive change in patients undergoing hypnotherapy for irritable bowel syndrome.
Gonsalkorale WM; Toner BB; Whorwell PJ
J Psychosom Res; 2004 Mar; 56(3):271-8. PubMed ID: 15046962
[TBL] [Abstract][Full Text] [Related]
4. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
[TBL] [Abstract][Full Text] [Related]
5. Hypnotherapy in irritable bowel syndrome: a large-scale audit of a clinical service with examination of factors influencing responsiveness.
Gonsalkorale WM; Houghton LA; Whorwell PJ
Am J Gastroenterol; 2002 Apr; 97(4):954-61. PubMed ID: 12003432
[TBL] [Abstract][Full Text] [Related]
6. Effect of gluten-free diet and co-morbidity of irritable bowel syndrome-type symptoms on health-related quality of life in adult coeliac patients.
Usai P; Manca R; Cuomo R; Lai MA; Boi MF
Dig Liver Dis; 2007 Sep; 39(9):824-8. PubMed ID: 17644056
[TBL] [Abstract][Full Text] [Related]
7. Hypnotherapy for irritable bowel syndrome in Saudi Arabian patients.
Al Sughayir MA
East Mediterr Health J; 2007; 13(2):301-8. PubMed ID: 17684852
[TBL] [Abstract][Full Text] [Related]
8. Patient satisfaction after gut-directed hypnotherapy in irritable bowel syndrome.
Lindfors P; Ljótsson B; Bjornsson E; Abrahamsson H; Simrén M
Neurogastroenterol Motil; 2013 Feb; 25(2):169-e86. PubMed ID: 23051178
[TBL] [Abstract][Full Text] [Related]
9. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
[TBL] [Abstract][Full Text] [Related]
10. Temporary sacral nerve stimulation for treatment of irritable bowel syndrome: a pilot study.
Lundby L; Krogh K; Buntzen S; Laurberg S
Dis Colon Rectum; 2008 Jul; 51(7):1074-8. PubMed ID: 18418655
[TBL] [Abstract][Full Text] [Related]
11. Internet-based assessment of bowel symptoms and quality of life.
Enck P; Kowalski A; Martens U; Klosterhalfen S
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1263-9. PubMed ID: 17099374
[TBL] [Abstract][Full Text] [Related]
12. Gut-directed hypnotherapy: the Manchester approach for treatment of irritable bowel syndrome.
Gonsalkorale WM
Int J Clin Exp Hypn; 2006 Jan; 54(1):27-50. PubMed ID: 16316882
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
14. No change in rectal sensitivity after gut-directed hypnotherapy in children with functional abdominal pain or irritable bowel syndrome.
Vlieger AM; van den Berg MM; Menko-Frankenhuis C; Bongers ME; Tromp E; Benninga MA
Am J Gastroenterol; 2010 Jan; 105(1):213-8. PubMed ID: 19861956
[TBL] [Abstract][Full Text] [Related]
15. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
Riedl A; Maass J; Fliege H; Stengel A; Schmidtmann M; Klapp BF; Mönnikes H
J Psychosom Res; 2009 Nov; 67(5):449-55. PubMed ID: 19837208
[TBL] [Abstract][Full Text] [Related]
16. Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome.
Watson ME; Lacey L; Kong S; Northcutt AR; McSorley D; Hahn B; Mangel AW
Am J Gastroenterol; 2001 Feb; 96(2):455-9. PubMed ID: 11232690
[TBL] [Abstract][Full Text] [Related]
17. Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials.
Lindfors P; Unge P; Arvidsson P; Nyhlin H; Björnsson E; Abrahamsson H; Simrén M
Am J Gastroenterol; 2012 Feb; 107(2):276-85. PubMed ID: 21971535
[TBL] [Abstract][Full Text] [Related]
18. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
[TBL] [Abstract][Full Text] [Related]
19. Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial.
Vlieger AM; Menko-Frankenhuis C; Wolfkamp SC; Tromp E; Benninga MA
Gastroenterology; 2007 Nov; 133(5):1430-6. PubMed ID: 17919634
[TBL] [Abstract][Full Text] [Related]
20. Women with irritable bowel syndrome and their perception of a good quality of life.
Bengtsson M; Ohlsson B; Ulander K
Gastroenterol Nurs; 2007; 30(2):74-82. PubMed ID: 17440306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
